共 11 条
- [5] Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment:: The M77001 study group [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4265 - 4274
- [6] National Bioethics Advisory Commission (NBAC), 2001, ETH POL ISS INT RES
- [9] SLAMON D, 2005, SAN ANT BREAST CANC